Winners of the 2026 CPHI Pharma Awards Highlight Innovations in Pharmaceutical Technology

Recognizing Excellence in Pharmaceutical Technology

The 2026 CPHI Pharma Awards honored winners across various categories during a celebration held on October 6, 2026, by Informa Markets. These awards emphasize progress in the pharmaceutical technology sector, celebrating individuals and companies that are pushing the boundaries of innovation in drug development, sustainability, and manufacturing.

Winners and Their Innovations

• API Development: MODAG for its combined platform for neurodegeneration.
• Digital Transformation: Evonik for the Self Driving Labs.
• Drug Delivery, Devices & Packaging Innovation: ForgeStop for its Secure Connected Packaging.
• Excellence With Purpose: Ministry of Health of Uzbekistan for making medicines affordable.
• Finished Formulation: SeraNovo for its formulation platform for oral drugs.
• Innovation Catalyst: Touchlight for its cell-free DNA platform.
• Manufacturing Excellence: Anemocyte for mRNA manufacturing innovations.
• Supply Chain Excellence: Almac Clinical Services for exemplary gene therapy supply chain management.
• Sustainable Pharma Excellence: Celtic Renewables for their green chemical revolution.
• Start-Up Initiative: Primogene for its Cell-Free Enzymatic Biomanufacturing Platform.

Leadership Recognition

The awards also recognized Future Leader Dr. Pauline van der Wijst-Janssen and Woman of the Year Emma Charles. CEO of the Year was awarded to Anil Okay, representing the high standard of leadership in the pharmaceutical industry.

The significance of these awards reflects the innovative practices that are increasingly defining the pharmaceutical landscape. Industry experts emphasized the collaborative efforts crucial for future advancements that directly benefit patients.